ArticleAnnals of hepato-biliary-pancreatic surgery2025
Global, regional, and national burden of gallbladder and biliary tract diseases: A systematic analysis of prevalence, incidence, deaths, and disability-adjusted life years with projections to 2050.
Article in Annals of hepato-biliary-pancreatic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Backgrounds/Aims: Gallbladder and biliary tract diseases include benign diseases of the gallbladder and biliary (BGB) as well as malignant neoplasms of the gallbladder and biliary tract (MGB). This study aimed to evaluate the global epidemiological trends and risk factors of gallbladder and biliary tract diseases, and to forecast their future trajectory. Methods: The estimated annual percentage change from 1990 to 2021 was calculated to evaluate trends in the age-standardized prevalence rate (ASPR), incidence rate (ASIR), death rate (ASDR), and disability-adjusted life years (DALYs) of gallbladder and biliary diseases. Results: At a regional level, higher socio-demographic index was linked to increased ASPR and ASIR for both BGB and MGB. In terms of geography, Central Europe reported the highest ASPR and ASIR among BGB patients. For MGB, the High-income Asia Pacific region demonstrated the highest ASPR, ASIR, and ASDR. Among individual countries, Honduras, Mexico, and Romania exhibited the greatest ASPR among those with BGB in 2021. The Republic of Korea reported the highest ASPR for MGB. In addition, Chile, Republic of Korea, and Thailand had a notably high ASIR, ASDR, and age-standardized DALYs for MGB. Female were more frequently affected by BGB than males. Conclusions: Despite a decline in age-standardized incidence and mortality rates, gallbladder and biliary tract diseases still impose a considerable health burden worldwide. Their prevalence demonstrates substantial regional, socioeconomic, age, and sex differences. Global health practitioners and policymakers should focus on timely identification of high-risk groups and initiation of targeted prevention strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.